Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

McMaster researchers to begin trials for new COVID vaccine

McMaster researchers ready to test two experimental vaccines and potentially produce millions of doses

2 min to read

Canada’s COVID-19 vaccine woes may soon have a made-in-Hamilton solution.

Researchers at McMaster University expect to soon begin clinical trials for two new so-called “second-generation” coronavirus vaccines that could help better protect people from new variants of the COVID virus.

Thanks for being a part of our community! Subscribe to get unlimited access.

Stay informed with The Hamilton Spectator.

Annual Deal
Digital Access

$49.99

for your first 12 months

Cancel anytime

Sign In Today

Already a subscriber?

We have recently updated our website. Please sign in to regain access to the site

Cancel anytime

Steve Buist
Steve Buist is an investigative reporter and feature writer with the Hamilton Spectator. He is the creator of the widely-acclaimed Code Red project, which examines the connections between health, social and economic factors in Hamilton. He has won four National Newspaper Awards, been named Canada’s Investigative Journalist of the Year three times, Ontario’s Journalist of the Year five times and past winner of the world’s top cancer reporting prize by the European School of Oncology.